Nursing Practice Updates
Updates focus on changes to legislation, SRNA bylaws, and the introduction of new standards and guidelines.
An interdisciplinary advisory group is working with SRNA staff to develop council policy that fully defines the educational, practicum, monitoring and audit requirements. The projected timeline to have policies approved by SRNA Council is by Dec. 31, 2018. SRNA will provide updates as the work progresses.
We have received interest from several RN(NP)s to support the environmental scan to inform SRNA Council regarding RN(NP)s authority to provide a medical certificate for medical cannabis and prescribe contrast dye. We anticipate this work to begin in November and will be in contact with individual RN(NP)s.
We are currently prioritizing several key projects focusing on the role and scope of RN(NP) practice. We are currently completing the Interpretation of Common Medical Disorders which is foundational to the practice of RN(NP)s.
Thank you for your ongoing support!
If you have any questions please contact Nursing Advisor, Donna Cooke at email@example.com | 306-359-4202
Starting on October 23, 2018, Health Canada has amended the Food and Drug Regulations to require a warning sticker and patient information handout be provided when dispensing Class A opioids. These requirements will ensure that all Canadians receive consistent information about the risks and safe use of opioids.
Currently in Saskatchewan, RN(NP)s licensed with the SRNA are the only authorized practitioners who can dispense opioids. When dispensing Class A opioids, the practitioner is required to ensure:
- The opioid warning sticker be affixed to the opioid bottle, container or package.
- The Opioid Patient Information handout must be given directly to the patient from the practitioner dispensing the opioid.
For more information, visit the Government of Canada’s website.